Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis

Advances in Virus Research

Volumn 81, Issue , 2011, Pages 165-199

  Ferrucci, Adriano ^a,b   Nonnemacher, Michael R ^b   Wigdahl, Brian ^b  

^a DREXEL UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Astrocyte; ATP; GSH; HIV; Neuron; Oxidative stress; Secretion; Vpr

Indexed keywords

EID: 81155151443     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385885-6.00010-9     Document Type: Chapter

References (131)

1. Acheampong E., Mukhtar M., Parveen Z., Ngoubilly N., Ahmad N., Patel C., Pomerantz R.J. Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells. Virology 2002, 304(2):222-234.
2. Agostini I., Navarro J.M., Rey F., Bouhamdan M., Spire B., Vigne R., Sire J. The human immunodeficiency virus type 1 Vpr transactivator: Cooperation with promoter-bound activator domains and binding to TFIIB. J. Mol. Biol. 1996, 261(5):599-606.
3. Ali S.A., Huang M.B., Campbell P.E., Roth W.W., Campbell T., Khan M., Newman G., Villinger F., Powell M.D., Bond V.C. Genetic characterization of HIV type 1 Nef-induced vesicle secretion. AIDS Res. Hum. Retroviruses 2010, 26(2):173-192.
4. Andersen J.L., Zimmerman E.S., DeHart J.L., Murala S., Ardon O., Blackett J., Chen J., Planelles V. ATR and GADD45alpha mediate HIV-1 Vpr-induced apoptosis. Cell Death Differ. 2005, 12(4):326-334.
5. Andersen J.L., DeHart J.L., Zimmerman E.S., Ardon O., Kim B., Jacquot G., Benichou S., Planelles V. HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT. PLoS Pathog. 2006, 2(12):e127.
6. Andersson L.M., Hagberg L., Fuchs D., Svennerholm B., Gisslen M. Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals-correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels. J. Neurovirol. 2001, 7(6):542-547.
7. Arokium H., Kamata M., Chen I. Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells. J. Virol. 2009, 83(21):11283-11297.
8. Arunagiri C., Macreadie I., Hewish D., Azad A. A C-terminal domain of HIV-1 accessory protein Vpr is involved in penetration, mitochondrial dysfunction and apoptosis of human CD4+ lymphocytes. Apoptosis 1997, 2(1):69-76.
9. Ayyavoo V., Mahalingam S., Rafaeli Y., Kudchodkar S., Chang D., Nagashunmugam T., Williams W.V., Weiner D.B. HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro. J. Leukoc. Biol. 1997, 62(1):93-99.
10. Ayyavoo V., Mahboubi A., Mahalingam S., Ramalingam R., Kudchodkar S., Williams W.V., Green D.R., Weiner D.B. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat. Med. 1997, 3(10):1117-1123.
11. Bachand F., Yao X.J., Hrimech M., Rougeau N., Cohen E.A. Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor. J. Biol. Chem. 1999, 274(13):9083-9091.
12. Balasubramanyam A., Mersmann H., Jahoor F., Phillips T.M., Sekhar R.V., Schubert U., Brar B., Iyer D., Smith E.O., Takahashi H., Lu H., Anderson P., et al. Effects of transgenic expression of HIV-1 Vpr on lipid and energy metabolism in mice. Am. J. Physiol. Endocrinol. Metab. 2007, 292(1):E40-E48.
13. Bukrinsky M., Adzhubei A. Viral protein R of HIV-1. Rev. Med. Virol. 1999, 9(1):39-49.
14. Campbell T.D., Khan M., Huang M.B., Bond V.C., Powell M.D. HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions. Ethn. Dis. 2008, 18(2 Suppl. 2). S2-14-S2-19.
15. Chang H.C., Samaniego F., Nair B.C., Buonaguro L., Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 1997, 11(12):1421-1431.
16. Cheng E.H., Levine B., Boise L.H., Thompson C.B., Hardwick J.M. Bax-independent inhibition of apoptosis by Bcl-XL. Nature 1996, 379(6565):554-556.
17. Chowdhury I.H., Wang X.F., Landau N.R., Robb M.L., Polonis V.R., Birx D.L., Kim J.H. HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: A potential mechanism of G2/M cell cycle arrest. Virology 2003, 305(2):371-377.
18. Churchill M.J., Gorry P.R., Cowley D., Lal L., Sonza S., Purcell D.F., Thompson K.A., Gabuzda D., McArthur J.C., Pardo C.A., Wesselingh S.L. Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. J. Neurovirol. 2006, 12(2):146-152.
19. Churchill M.J., Wesselingh S.L., Cowley D., Pardo C.A., McArthur J.C., Brew B.J., Gorry P.R. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann. Neurol. 2009, 66(2):253-258.
20. Coeytaux E., Coulaud D., Le Cam E., Danos O., Kichler A. The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J. Biol. Chem. 2003, 278(20):18110-18116.
21. Cohen E.A., Dehni G., Sodroski J.G., Haseltine W.A. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 1990, 64(6):3097-3099.
22. Cohen E.A., Terwilliger E.F., Jalinoos Y., Proulx J., Sodroski J.G., Haseltine W.A. Identification of HIV-1 vpr product and function. J. Acquir. Immune Defic. Syndr. 1990, 3(1):11-18.
23. Conti L., Rainaldi G., Matarrese P., Varano B., Rivabene R., Columba S., Sato A., Belardelli F., Malorni W., Gessani S. The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: Possible implications for the pathogenesis of AIDS. J. Exp. Med. 1998, 187(3):403-413.
24. Conti L., Matarrese P., Varano B., Gauzzi M.C., Sato A., Malorni W., Belardelli F., Gessani S. Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells. J. Immunol. 2000, 165(6):3293-3300.
25. Dallasta L.M., Pisarov L.A., Esplen J.E., Werley J.V., Moses A.V., Nelson J.A., Achim C.L. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 1999, 155(6):1915-1927.
26. Deshmane S.L., Mukerjee R., Fan S., Del Valle L., Michiels C., Sweet T., Rom I., Khalili K., Rappaport J., Amini S., Sawaya B.E. Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J. Biol. Chem. 2009, 284(17):11364-11373.
27. Di Marzio P., Choe S., Ebright M., Knoblauch R., Landau N.R. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 1995, 69(12):7909-7916.
28. Dringen R., Kussmaul L., Gutterer J.M., Hirrlinger J., Hamprecht B. The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J. Neurochem. 1999, 72(6):2523-2530.
29. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., Wingfield P., Gallo R.C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 1993, 67(1):277-287.
30. Eugenin E.A., Osiecki K., Lopez L., Goldstein H., Calderon T.M., Berman J.W. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: A potential mechanism of HIV-CNS invasion and neuroAIDS. J. Neurosci. 2006, 26(4):1098-1106.
31. Felzien L.K., Woffendin C., Hottiger M.O., Subbramanian R.A., Cohen E.A., Nabel G.J. HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. Proc. Natl. Acad. Sci. USA 1998, 95(9):5281-5286.
32. Fritz J.V., Didier P., Clamme J.P., Schaub E., Muriaux D., Cabanne C., Morellet N., Bouaziz S., Darlix J.L., Mely Y., de Rocquigny H. Direct Vpr-Vpr interaction in cells monitored by two photon fluorescence correlation spectroscopy and fluorescence lifetime imaging. Retrovirology 2008, 5:87.
33. Fukumori T., Akari H., Iida S., Hata S., Kagawa S., Aida Y., Koyama A.H., Adachi A. The HIV-1 Vpr displays strong anti-apoptotic activity. FEBS Lett. 1998, 432(1-2):17-20.
34. Fukumori T., Akari H., Yoshida A., Fujita M., Koyama A.H., Kagawa S., Adachi A. Regulation of cell cycle and apoptosis by human immunodeficiency virus type 1 Vpr. Microbes Infect. 2000, 2(9):1011-1017.
35. Garg S.K., Banerjee R., Kipnis J. Neuroprotective immunity: T cell-derived glutamate endows astrocytes with a neuroprotective phenotype. J. Immunol. 2008, 180(6):3866-3873.
36. Giulian D., Wendt E., Vaca K., Noonan C.A. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. USA 1993, 90(7):2769-2773.
37. Goh W.C., Rogel M.E., Kinsey C.M., Michael S.F., Fultz P.N., Nowak M.A., Hahn B.H., Emerman M. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo. Nat. Med. 1998, 4(1):65-71.
38. Goh W.C., Manel N., Emerman M. The human immunodeficiency virus Vpr protein binds Cdc25C: Implications for G2 arrest. Virology 2004, 318(1):337-349.
39. Hallenberger S., Tucker S.P., Owens R.J., Bernstein H.B., Compans R.W. Secretion of a truncated form of the human immunodeficiency virus type 1 envelope glycoprotein. Virology 1993, 193(1):510-514.
40. Hart T.K., Kirsh R., Ellens H., Sweet R.W., Lambert D.M., Petteway S.R., Leary J., Bugelski P.J. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 1991, 88(6):2189-2193.
41. He J., Choe S., Walker R., Di Marzio P., Morgan D.O., Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 1995, 69(11):6705-6711.
42. Heinzinger N.K., Bukinsky M.I., Haggerty S.A., Ragland A.M., Kewalramani V., Lee M.A., Gendelman H.E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 1994, 91(15):7311-7315.
43. Henklein P., Bruns K., Sherman M.P., Tessmer U., Licha K., Kopp J., de Noronha C.M., Greene W.C., Wray V., Schubert U. Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest. J. Biol. Chem. 2000, 275(41):32016-32026.
44. Herzenberg L.A., De Rosa S.C., Dubs J.G., Roederer M., Anderson M.T., Ela S.W., Deresinski S.C. Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. USA 1997, 94(5):1967-1972.
45. Hickey W.F. Leukocyte traffic in the central nervous system: The participants and their roles. Semin. Immunol. 1999, 11(2):125-137.
46. Hoshino S., Sun B., Konishi M., Shimura M., Segawa T., Hagiwara Y., Koyanagi Y., Iwamoto A., Mimaya J., Terunuma H., Kano S., Ishizaka Y. Vpr in plasma of HIV type 1-positive patients is correlated with the HIV type 1 RNA titers. AIDS Res. Hum. Retroviruses 2007, 23(3):391-397.
47. Hoshino S., Konishi M., Mori M., Shimura M., Nishitani C., Kuroki Y., Koyanagi Y., Kano S., Itabe H., Ishizaka Y. HIV-1 Vpr induces TLR4/MyD88-mediated IL-6 production and reactivates viral production from latency. J. Leukoc. Biol. 2010, 87(6):1133-1143.
48. Hrimech M., Yao X.J., Bachand F., Rougeau N., Cohen E.A. Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection. J. Virol. 1999, 73(5):4101-4109.
49. Huang M., Orenstein J.M., Martin M.A., Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 1995, 69(11):6810-6818.
50. Huang M.B., Weeks O., Zhao L.J., Saltarelli M., Bond V.C. Effects of extracellular human immunodeficiency virus type 1 vpr protein in primary rat cortical cell cultures. J. Neurovirol. 2000, 6(3):202-220.
51. Ishibashi T., Dakin K.A., Stevens B., Lee P.R., Kozlov S.V., Stewart C.L., Fields R.D. Astrocytes promote myelination in response to electrical impulses. Neuron 2006, 49(6):823-832.
52. Jacotot E., Ravagnan L., Loeffler M., Ferri K.F., Vieira H.L., Zamzami N., Costantini P., Druillennec S., Hoebeke J., Briand J.P., Irinopoulou T., Daugas E., et al. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med. 2000, 191(1):33-46.
53. Jacotot E., Ferri K.F., El Hamel C., Brenner C., Druillennec S., Hoebeke J., Rustin P., Metivier D., Lenoir C., Geuskens M., Vieira H.L., Loeffler M., et al. Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J. Exp. Med. 2001, 193(4):509-519.
54. James C.O., Huang M.B., Khan M., Garcia-Barrio M., Powell M.D., Bond V.C. Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors. J. Virol. 2004, 78(6):3099-3109.
55. Jian H., Zhao L.J. Pro-apoptotic activity of HIV-1 auxiliary regulatory protein Vpr is subtype-dependent and potently enhanced by nonconservative changes of the leucine residue at position 64. J. Biol. Chem. 2003, 278(45):44326-44330.
56. Jones G.J., Barsby N.L., Cohen E.A., Holden J., Harris K., Dickie P., Jhamandas J., Power C. HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration. J. Neurosci. 2007, 27(14):3703-3711.
57. Kamata M., Aida Y. Two putative alpha-helical domains of human immunodeficiency virus type 1 Vpr mediate nuclear localization by at least two mechanisms. J. Virol. 2000, 74(15):7179-7186.
58. Kanmogne G.D., Kennedy R.C., Grammas P. HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: Possible pathway for HIV entry into the brain and HIV-associated dementia. J. Neuropathol. Exp. Neurol. 2002, 61(11):992-1000.
59. Kichler A., Pages J.C., Leborgne C., Druillennec S., Lenoir C., Coulaud D., Delain E., Le Cam E., Roques B.P., Danos O. Efficient DNA transfection mediated by the C-terminal domain of human immunodeficiency virus type 1 viral protein R. J. Virol. 2000, 74(12):5424-5431.
60. Kitayama H., Miura Y., Ando Y., Hoshino S., Ishizaka Y., Koyanagi Y. Human immunodeficiency virus type 1 Vpr inhibits axonal outgrowth through induction of mitochondrial dysfunction. J. Virol. 2008, 82(5):2528-2542.
61. Kondo E., Mammano F., Cohen E.A., Gottlinger H.G. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J. Virol. 1995, 69(5):2759-2764.
62. Lenassi M., Cagney G., Liao M., Vaupotic T., Bartholomeeusen K., Cheng Y., Krogan N.J., Plemenitas A., Peterlin B.M. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 2010, 11(1):110-122.
63. Levy D.N., Fernandes L.S., Williams W.V., Weiner D.B. Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 1993, 72(4):541-550.
64. Levy D.N., Refaeli Y., MacGregor R.R., Weiner D.B. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 1994, 91(23):10873-10877.
65. Levy D.N., Refaeli Y., Weiner D.B. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 1995, 69(2):1243-1252.
66. Li Y., Luo L., Thomas D.Y., Kang C.Y. Control of expression, glycosylation, and secretion of HIV-1 gp120 by homologous and heterologous signal sequences. Virology 1994, 204(1):266-278.
67. Liu N.Q., Lossinsky A.S., Popik W., Li X., Gujuluva C., Kriederman B., Roberts J., Pushkarsky T., Bukrinsky M., Witte M., Weinand M., Fiala M. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J. Virol. 2002, 76(13):6689-6700.
68. Lu Y.L., Spearman P., Ratner L. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 1993, 67(11):6542-6550.
69. Macreadie I.G., Castelli L.A., Hewish D.R., Kirkpatrick A., Ward A.C., Azad A.A. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc. Natl. Acad. Sci. USA 1995, 92(7):2770-2774.
70. Macreadie I.G., Arunagiri C.K., Hewish D.R., White J.F., Azad A.A. Extracellular addition of a domain of HIV-1 Vpr containing the amino acid sequence motif H(S/F)RIG causes cell membrane permeabilization and death. Mol. Microbiol. 1996, 19(6):1185-1192.
71. Macreadie I.G., Fernley R., Castelli L.A., Lucantoni A., White J., Azad A. Expression of HIV-1 nef in yeast causes membrane perturbation and release of the myristylated Nef protein. J. Biomed. Sci. 1998, 5(3):203-210.
72. Mahalingam S., Ayyavoo V., Patel M., Kieber-Emmons T., Kao G.D., Muschel R.J., Weiner D.B. HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle. Proc. Natl. Acad. Sci. USA 1998, 95(7):3419-3424.
73. Majumder B., Janket M.L., Schafer E.A., Schaubert K., Huang X.L., Kan-Mitchell J., Rinaldo C.R., Ayyavoo V. Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: Implications for viral immune escape. J. Virol. 2005, 79(13):7990-8003.
74. Majumder B., Venkatachari N.J., Schafer E.A., Janket M.L., Ayyavoo V. Dendritic cells infected with vpr-positive human immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of tumor necrosis factor alpha. J. Virol. 2007, 81(14):7388-7399.
75. Majumder B., Venkatachari N.J., O'Leary S., Ayyavoo V. Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells. J. Virol. 2008, 82(14):7189-7200.
76. Majumder B., Venkatachari N.J., Srinivasan A., Ayyavoo V. HIV-1 mediated immune pathogenesis: Spotlight on the role of viral protein R (Vpr). Curr. HIV Res. 2009, 7(2):169-177.
77. Matarrese P., Conti L., Varano B., Gauzzi M.C., Belardelli F., Gessani S., Malorni W. The HIV-1 vpr protein induces anoikis-resistance by modulating cell adhesion process and microfilament system assembly. Cell Death Differ. 2000, 7(1):25-36.
78. Michaels J., Price R.W., Rosenblum M.K. Microglia in the giant cell encephalitis of acquired immune deficiency syndrome: Proliferation, infection and fusion. Acta Neuropathol. 1988, 76(4):373-379.
79. Mishra S., Mishra J.P., Kumar A. Activation of JNK-dependent pathway is required for HIV viral protein R-induced apoptosis in human monocytic cells: Involvement of antiapoptotic BCL2 and c-IAP1 genes. J. Biol. Chem. 2007, 282(7):4288-4300.
80. Mizoguchi I., Ooe Y., Hoshino S., Shimura M., Kasahara T., Kano S., Ohta T., Takaku F., Nakayama Y., Ishizaka Y. Improved gene expression in resting macrophages using an oligopeptide derived from Vpr of human immunodeficiency virus type-1. Biochem. Biophys. Res. Commun. 2005, 338(3):1499-1506.
81. Morellet N., Bouaziz S., Petitjean P., Roques B.P. NMR structure of the HIV-1 regulatory protein VPR. J. Mol. Biol. 2003, 327(1):215-227.
82. Morellet N., Roques B.P., Bouaziz S. Structure-function relationship of Vpr: Biological implications. Curr. HIV Res. 2009, 7(2):184-210.
83. Muthumani K., Hwang D.S., Dayes N.S., Kim J.J., Weiner D.B. The HIV-1 accessory gene vpr can inhibit antigen-specific immune function. DNA Cell Biol. 2002, 21(9):689-695.
84. Muthumani K., Hwang D.S., Choo A.Y., Mayilvahanan S., Dayes N.S., Thieu K.P., Weiner D.B. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. Int. Immunol. 2005, 17(2):103-116.
85. Nakamura T., Suzuki H., Okamoto T., Kotani S., Atsuji Y., Tanaka T., Ito Y. Recombinant Vpr (rVpr) causes augmentation of HIV-1 p24 Ag level in U1 cells through its ability to induce the secretion of TNF. Virus Res. 2002, 90(1-2):263-268.
86. Nonaka M., Hashimoto Y., Takeshima S.N., Aida Y. The human immunodeficiency virus type 1 Vpr protein and its carboxy-terminally truncated form induce apoptosis in tumor cells. Cancer Cell Int. 2009, 9:20.
87. Noorbakhsh F., Ramachandran R., Barsby N., Ellestad K.K., LeBlanc A., Dickie P., Baker G., Hollenberg M.D., Cohen E.A., Power C. MicroRNA profiling reveals new aspects of HIV neurodegeneration: Caspase-6 regulates astrocyte survival. FASEB J. 2010, 24(6):1799-1812.
88. Ogawa K., Shibata R., Kiyomasu T., Higuchi I., Kishida Y., Ishimoto A., Adachi A. Mutational analysis of the human immunodeficiency virus vpr open reading frame. J. Virol. 1989, 63(9):4110-4114.
89. Paxton W., Connor R.I., Landau N.R. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 1993, 67(12):7229-7237.
90. Pellerin L., Magistretti P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: A mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. USA 1994, 91(22):10625-10629.
91. Piller S.C., Ewart G.D., Premkumar A., Cox G.B., Gage P.W. Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers. Proc. Natl. Acad. Sci. USA 1996, 93(1):111-115.
92. Piller S.C., Jans P., Gage P.W., Jans D.A. Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: Implications for AIDS pathology. Proc. Natl. Acad. Sci. USA 1998, 95(8):4595-4600.
93. Ransohoff R.M. Snip-snip, kill-kill: Truncated SDF-1 and HIV-associated neurodegeneration. Nat. Neurosci. 2003, 6(10):1009-1011.
94. Re D.B., Nafia I., Melon C., Shimamoto K., Kerkerian-Le Goff L., Had-Aissouni L. Glutamate leakage from a compartmentalized intracellular metabolic pool and activation of the lipoxygenase pathway mediate oxidative astrocyte death by reversed glutamate transport. Glia 2006, 54(1):47-57.
95. Reiss P., Lange J.M., de Ronde A., de Wolf F., Dekker J., Danner S.A., Debouck C., Goudsmit J. Antibody response to viral proteins U (vpu) and R (vpr) in HIV-1-infected individuals. J. Acquir. Immune Defic. Syndr. 1990, 3(2):115-122.
96. Richardson M.W., Mirchandani J., Duong J., Grimaldo S., Kocieda V., Hendel H., Khalili K., Zagury J.F., Rappaport J. Antibodies to Tat and Vpr in the GRIV cohort: Differential association with maintenance of long-term non-progression status in HIV-1 infection. Biomed. Pharmacother. 2003, 57(1):4-14.
97. + -dependent high-affinity glutamate transport in macrophages. J. Immunol. 2000, 164(10):5430-5438.
98. Rom I., Deshmane S.L., Mukerjee R., Khalili K., Amini S., Sawaya B.E. HIV-1 Vpr deregulates calcium secretion in neural cells. Brain Res. 2009, 1275:81-86.
99. Romani B., Engelbrecht S. Human immunodeficiency virus type 1 Vpr: Functions and molecular interactions. J. Gen. Virol. 2009, 90(Pt 8):1795-1805.
100. Roumier T., Vieira H.L., Castedo M., Ferri K.F., Boya P., Andreau K., Druillennec S., Joza N., Penninger J.M., Roques B., Kroemer G. The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway. Cell Death Differ. 2002, 9(11):1212-1219.
101. Ryglewski S., Pflueger H.J., Duch C. Expanding the neuron's calcium signaling repertoire: Intracellular calcium release via voltage-induced PLC and IP3R activation. PLoS Biol. 2007, 5(4):e66.
102. Sabbah E.N., Roques B.P. Critical implication of the (70-96) domain of human immunodeficiency virus type 1 Vpr protein in apoptosis of primary rat cortical and striatal neurons. J. Neurovirol. 2005, 11(6):489-502.
103. Sabbah E.N., Druillennec S., Morellet N., Bouaziz S., Kroemer G., Roques B.P. Interaction between the HIV-1 protein Vpr and the adenine nucleotide translocator. Chem. Biol. Drug Des. 2006, 67(2):145-154.
104. Sattentau Q.J., Dalgleish A.G., Weiss R.A., Beverley P.C. Epitopes of the CD4 antigen and HIV infection. Science 1986, 234(4780):1120-1123.
105. Sawaya B.E., Khalili K., Mercer W.E., Denisova L., Amini S. Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J. Biol. Chem. 1998, 273(32):20052-20057.
106. Sawaya B.E., Khalili K., Gordon J., Taube R., Amini S. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J. Biol. Chem. 2000, 275(45):35209-35214.
107. Scemes E., Giaume C. Astrocyte calcium waves: What they are and what they do. Glia 2006, 54(7):716-725.
108. Sherman M.P., de Noronha C.M., Heusch M.I., Greene S., Greene W.C. Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr. J. Virol. 2001, 75(3):1522-1532.
109. Sherman M.P., Schubert U., Williams S.A., de Noronha C.M., Kreisberg J.F., Henklein P., Greene W.C. HIV-1 Vpr displays natural protein-transducing properties: Implications for viral pathogenesis. Virology 2002, 302(1):95-105.
110. Sherman M.P., de Noronha C.M., Eckstein L.A., Hataye J., Mundt P., Williams S.A., Neidleman J.A., Goldsmith M.A., Greene W.C. Nuclear export of Vpr is required for efficient replication of human immunodeficiency virus type 1 in tissue macrophages. J. Virol. 2003, 77(13):7582-7589.
111. Stauber R.H., Pavlakis G.N. Intracellular trafficking and interactions of the HIV-1 Tat protein. Virology 1998, 252(1):126-136.
112. Stewart S.A., Poon B., Jowett J.B., Chen I.S. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 1997, 71(7):5579-5592.
113. Stewart S.A., Poon B., Song J.Y., Chen I.S. Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation. J. Virol. 2000, 74(7):3105-3111.
114. Subbramanian R.A., Kessous-Elbaz A., Lodge R., Forget J., Yao X.J., Bergeron D., Cohen E.A. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J. Exp. Med. 1998, 187(7):1103-1111.
115. Taguchi T., Shimura M., Osawa Y., Suzuki Y., Mizoguchi I., Niino K., Takaku F., Ishizaka Y. Nuclear trafficking of macromolecules by an oligopeptide derived from Vpr of human immunodeficiency virus type-1. Biochem. Biophys. Res. Commun. 2004, 320(1):18-26.
116. Varin A., Decrion A.Z., Sabbah E., Quivy V., Sire J., Van Lint C., Roques B.P., Aggarwal B.B., Herbein G. Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. J. Biol. Chem. 2005, 280(52):42557-42567.
117. Vendeville A., Rayne F., Bonhoure A., Bettache N., Montcourrier P., Beaumelle B. HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol. Biol. Cell 2004, 15(5):2347-2360.
118. Venkatachari N.J., Walker L.A., Tastan O., Le T., Dempsey T.M., Li Y., Yanamala N., Srinivasan A., Klein-Seetharaman J., Montelaro R.C., Ayyavoo V. Human immunodeficiency virus type 1 Vpr: Oligomerization is an essential feature for its incorporation into virus particles. Virol. J. 2010, 7(1):119.
119. Vesce S., Bezzi P., Rossi D., Meldolesi J., Volterra A. HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett. 1997, 411(1):107-109.
120. Vieira H.L., Haouzi D., El Hamel C., Jacotot E., Belzacq A.S., Brenner C., Kroemer G. Permeabilization of the mitochondrial inner membrane during apoptosis: Impact of the adenine nucleotide translocator. Cell Death Differ. 2000, 7(12):1146-1154.
121. Waldhuber M.G., Bateson M., Tan J., Greenway A.L., McPhee D.A. Studies with GFP-Vpr fusion proteins: Induction of apoptosis but ablation of cell-cycle arrest despite nuclear membrane or nuclear localization. Virology 2003, 313(1):91-104.
122. Wang L., Mukherjee S., Jia F., Narayan O., Zhao L.J. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J. Biol. Chem. 1995, 270(43):25564-25569.
123. Wang Z., Pekarskaya O., Bencheikh M., Chao W., Gelbard H.A., Ghorpade A., Rothstein J.D., Volsky D.J. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 2003, 312(1):60-73.
124. Wang H., Sun J., Goldstein H. Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide. J. Virol. 2008, 82(15):7591-7600.
125. Williams K.C., Hickey W.F. Traffic of lymphocytes into the CNS during inflammation and HIV infection. J. NeuroAIDS 1996, 1(1):31-55.
126. Xiao Y., Chen G., Richard J., Rougeau N., Li H., Seidah N.G., Cohen E.A. Cell-surface processing of extracellular human immunodeficiency virus type 1 Vpr by proprotein convertases. Virology 2008, 372(2):384-397.
127. Yang Y., Tikhonov I., Ruckwardt T.J., Djavani M., Zapata J.C., Pauza C.D., Salvato M.S. Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. J. Virol. 2003, 77(12):6700-6708.
128. Yuan X., Matsuda Z., Matsuda M., Essex M., Lee T.H. Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res. Hum. Retroviruses 1990, 6(11):1265-1271.
129. Zhang S., Pointer D., Singer G., Feng Y., Park K., Zhao L.J. Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1. Gene 1998, 212(2):157-166.
130. Zhao L.J., Wang L., Mukherjee S., Narayan O. Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. J. Biol. Chem. 1994, 269(51):32131-32137.
131. Zhu Y., Roshal M., Li F., Blackett J., Planelles V. Upregulation of survivin by HIV-1 Vpr. Apoptosis 2003, 8(1):71-79.